Should you invest $1,000 in Anheuser-busch Inbev Sa/nv right now?

Before you buy stock in Anheuser-busch Inbev Sa/nv, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Anheuser-busch Inbev Sa/nv wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $20,697.16!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 29 percentage points since 2013*.

See the Top Stocks * Returns as of 3/20/25

TFSA Investors: 2 U.S. Stocks I’m Never Selling

Canadians looking to diversify their portfolios and gain exposure to U.S. stocks can purchase shares of high-growth companies such as The Trade Desk and benefit from exponential gains.

| More on:

The Tax-Free Savings Account (TFSA) is a popular registered account among Canadians. Launched in 2009, the TFSA encourages savings and investments, as any withdrawal from the account is exempt from Canada Revenue Agency taxes.

Canadians can hold several asset classes in a TFSA that include stocks, bonds, and mutual funds. Investors can also buy and hold equities from exchanges south of the border, to further diversify their portfolio.

Here, we look at two U.S. stocks that I believe should be a part of your TFSA portfolio in 2022.

Green Thumb Industries

The first stock on my list is Green Thumb Industries (CNSX:GTII), a U.S.-based cannabis producer valued at a market cap of US$3 billion. Headquartered in Chicago, Illinois, Green Thumb has 17 manufacturing facilities and 77 retail locations across 15 states in the U.S.

The company manufactures and distributes a portfolio of branded cannabis products. It also owns and operates a chain of retail cannabis stores called RISE, which is fast gaining traction across the country.

Due to the recent wave of legalization in the U.S., Green Thumb has managed to increase sales from US$62.5 million in 2018 to US$893.56 million in 2021. In Q2, its sales rose by 14.6% year-over-year to US$254.3 million. It has now reported eight consecutive quarters of positive GAAP (generally accepted accounting principles) net income which stood at US$24.4 million or US$0.10 per diluted share in the June quarter.

Green Thumb’s adjusted operating EBITDA (earnings before interest, tax, depreciation, and amortization) rose 17.4% to US$78.7 million in Q2, accounting for 31% of sales. In the first six months of 2022, its operating cash flow stood at US$40 million.

Analysts also expect company sales to touch US$1.6 billion in 2023, valuing the stock at a forward price to sales multiple of 2.

Green Thumb stock is down 73% from all-time highs. But its now trading at a discount of 170% compared to consensus price target estimates. Now would be a good time to consider Green Thumb stock.

The Trade Desk

One of the largest players in the programmatic advertising segment, The Trade Desk (NASDAQ:TTD) is a solid long-term bet. Down 50% from all-time highs, TTD’s stock price has still surged 1,700% since its IPO in 2016.

Several tech giants such as Meta Platforms, Snap, and Twitter reported revenue and earnings below consensus estimates in Q2 due to a challenging macro-economic environment. However, The Trade Desk’s sales rose 35% year-over-year in Q2 to US$377 million while adjusted earnings surged 11% to US$0.20 per share. Analysts forecast sales and EPS (earnings per share) at US$365 million and US$0.20 per share, respectively.

TTD’s co-founder and CEO Jeff Green commented that the company’s stellar performance in Q2 provides the management team with confidence in gaining market share across economic cycles. It also continues to invest in verticals such as identity, connected TV, retail media, and supply chain optimization.

The Trade Desk has signed several partnerships with the world’s leading broadcasters, retailers, and publishers which should drive future revenue growth.

TTD now expects revenue of US$385 million and adjusted EBITDA of US$140 million in Q3. Analysts tracking TTD stock, forecast sales to touch US$382.2 million in the September quarter.

Due to the recent sell-off, TTD stock price is trading at a discount of almost 50% compared to consensus price target estimates. Considering its future growth potential, this stock offers a great opportunity to diversify your TFSA portfolio.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends The Trade Desk. The Motley Fool recommends Green Thumb Industries.

More on Cannabis Stocks

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »